| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 4902-4914, Copyright © 1996 by Endocrine Society
ARTICLES |
P Pedraza, R Calvo, MJ Obregon, M Asuncion, F Escobar del Rey and GM Morreale de Escobar
Unidad de Endocrinologia Molecular, Consejo Superior de Investigaciones Cientificas, Madrid, Spain.
EMD 21388 displaces T4 from circulating transthyretin, is a potent in vitro inhibitor of outer-ring deiodination (5'D) of T4 and affects thyroid hormone secretion. To study its extrathyroidal effects on the thyroid hormone status of pregnant dams and their fetuses, we treated the dams with methimazole and infused them with T4 and with either 2.5 mg EMD 21388/rat per day [(EMD(+)], or placebo solution [EMD(-)]. EMD reduced total T4 and T3 in the maternal circulation, but free T4 increased and free T3 decreased. The total amount of T3 generated from T4 in the maternal compartment increased. Placental T3 also increased in EMD(+) animals, T4 remaining the same. EMD also reached the fetal circulation. The total fetal extrathyroidal T4 pool decreased to half that of EMD(-) fetuses, whereas T3 increased 1.8-fold, thus mitigating fetal T3 deficiency, especially in the lung. Thus, if the maternal supply of T4 is kept constant, EMD mitigates the T3 deficiency of many tissues of the hypothyroid fetus. Most of the effects of this dose of EMD could result from the displacement of T4 from circulating transthyretin. Liver 5'D-I activity did not decrease, but actually increased by 40% in dams and fetuses. The enhanced transfer of T4 into tissues would also increase the amount of substrate available to 5'D-I, leading to an increased amount of T3 in maternal and fetal pools. This had not been anticipated from the changes in circulating T4 and T3, whether maternal or fetal, total or free.
This article has been cited by other articles:
![]() |
Y. Kato, S. Ikushiro, K. Haraguchi, T. Yamazaki, Y. Ito, H. Suzuki, R. Kimura, S. Yamada, T. Inoue, and M. Degawa A Possible Mechanism for Decrease in Serum Thyroxine Level by Polychlorinated Biphenyls in Wistar and Gunn Rats Toxicol. Sci., October 1, 2004; 81(2): 309 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Martinez-deMena, A. Hernandez, and M.-J. Obregon Triiodothyronine is required for the stimulation of type II 5'-deiodinase mRNA in rat brown adipocytes Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1119 - E1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elnour, L. Hambraeus, M. Eltom, M. Dramaix, and P. Bourdoux Endemic goiter with iodine sufficiency: a possible role for the consumption of pearl millet in the etiology of endemic goiter1 Am. J. Clinical Nutrition, January 1, 2000; 71(1): 59 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. S.-V. D. Elst, D. Van Der Heide, H. Rokos, G. M. De Escobar, and J. Kohrle Synthetic flavonoids cross the placenta in the rat and are found in fetal brain Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E253 - E256. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |